TY - JOUR
T1 - Absence of an orphan mitochondrial protein, C19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation
AU - Hartig, Monika B.
AU - Iuso, Arcangela
AU - Haack, Tobias
AU - Kmiec, Tomasz
AU - Jurkiewicz, Elzbieta
AU - Heim, Katharina
AU - Roeber, Sigrun
AU - Tarabin, Victoria
AU - Dusi, Sabrina
AU - Krajewska-Walasek, Malgorzata
AU - Jozwiak, Sergiusz
AU - Hempel, Maja
AU - Winkelmann, Juliane
AU - Elstner, Matthias
AU - Oexle, Konrad
AU - Klopstock, Thomas
AU - Mueller-Felber, Wolfgang
AU - Gasser, Thomas
AU - Trenkwalder, Claudia
AU - Tiranti, Valeria
AU - Kretzschmar, Hans
AU - Schmitz, Gerd
AU - Strom, Tim M.
AU - Meitinger, Thomas
AU - Prokisch, Holger
N1 - Funding Information:
We are indebted to all individuals and their families donating samples and clinical datasets. We thank I. Gromek, A. Kostera-Pruszczyk, B. Lojszczyk, and B. Chipczynska for their efforts in clinical phenotyping. We gratefully acknowledge the support of R. Hellinger and A. Löschner in genotyping; B. Schmick, K. Junghans, and B. Siegel in expression analysis; and S. Heinisch in bioinformatics analysis. T.M. and H.P. were supported by the Impulse and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Health in an Ageing Society (HA-215), the German National Research Network (NGFNplus #01GS08134), the German Network for Mitochondrial Disorders (mitoNET 01GM0867), and Systems Biology of Metabotypes (SysMBo #0315494A). T.K. is supported by the German Network for Mitochondrial Disorders (mitoNET #01GM0862). J.W. and K.O. are supported by a grant from the Deutsche Forschungsgemeinschaft (WI 1820/4-1). The Brain-Net is supported by the Federal Ministry of Education and Research (BMBF). Work on primary human adipocytes was supported by the seventh framework program of the European-Union-funded LipidomicNet (proposal 202272). S.D. is supported by Italian Foundation AISNAF (Associazione Italiana Sindromi Neurodegenerative Accumulo di Ferro). The financial support of Mariani Foundation of Milan (grant R-10-84 to V.T.) is gratefully acknowledged.
PY - 2011/10/7
Y1 - 2011/10/7
N2 - The disease classification neurodegeneration with brain iron accumulation (NBIA) comprises a clinically and genetically heterogeneous group of progressive neurodegenerative disorders characterized by brain iron deposits in the basal ganglia. For about half of the cases, the molecular basis is currently unknown. We used homozygosity mapping followed by candidate gene sequencing to identify a homozygous 11 bp deletion in the orphan gene C19orf12. Mutation screening of 23 ideopathic NBIA index cases revealed two mutated alleles in 18 of them, and one loss-of-function mutation is the most prevalent. We also identified compound heterozygous missense mutations in a case initially diagnosed with Parkinson disease at age 49. Psychiatric signs, optic atrophy, and motor axonal neuropathy were common findings. Compared to the most prevalent NBIA subtype, pantothenate kinase associated neurodegeneration (PKAN), individuals with two C19orf12 mutations were older at age of onset and the disease progressed more slowly. A polyclonal antibody against the predicted membrane spanning protein showed a mitochondrial localization. A histopathological examination in a single autopsy case detected Lewy bodies, tangles, spheroids, and tau pathology. The mitochondrial localization together with the immunohistopathological findings suggests a pathomechanistic overlap with common forms of neurodegenerative disorders.
AB - The disease classification neurodegeneration with brain iron accumulation (NBIA) comprises a clinically and genetically heterogeneous group of progressive neurodegenerative disorders characterized by brain iron deposits in the basal ganglia. For about half of the cases, the molecular basis is currently unknown. We used homozygosity mapping followed by candidate gene sequencing to identify a homozygous 11 bp deletion in the orphan gene C19orf12. Mutation screening of 23 ideopathic NBIA index cases revealed two mutated alleles in 18 of them, and one loss-of-function mutation is the most prevalent. We also identified compound heterozygous missense mutations in a case initially diagnosed with Parkinson disease at age 49. Psychiatric signs, optic atrophy, and motor axonal neuropathy were common findings. Compared to the most prevalent NBIA subtype, pantothenate kinase associated neurodegeneration (PKAN), individuals with two C19orf12 mutations were older at age of onset and the disease progressed more slowly. A polyclonal antibody against the predicted membrane spanning protein showed a mitochondrial localization. A histopathological examination in a single autopsy case detected Lewy bodies, tangles, spheroids, and tau pathology. The mitochondrial localization together with the immunohistopathological findings suggests a pathomechanistic overlap with common forms of neurodegenerative disorders.
UR - http://www.scopus.com/inward/record.url?scp=80053916609&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2011.09.007
DO - 10.1016/j.ajhg.2011.09.007
M3 - Article
C2 - 21981780
AN - SCOPUS:80053916609
SN - 0002-9297
VL - 89
SP - 543
EP - 550
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 4
ER -